|
|
Courses – Day by Day
| Saturday |
Sunday|
Monday |
Tuesday |
This programme may be subject to minor changes.
SATURDAY, JUNE 9
14.30 - 16.00 Room I
EGS/SOE Course
C01 - Early diagnosis of POAG
Moderator: Hans Lemij, The Netherlands
Early detection of glaucoma with various imaging devices
Ted Garway-Heath, United Kingdom
Exploring early glaucoma with the GDx VCC
Nic Reus, The Netherlands
Synopsis:
The role of sophisticated imaging devices in the management of
glaucoma is on the increase, both for making a diagnosis and for
detecting progression. Several studies suggest that structural
measurements of the optic nerve head and retinal nerve fibre layer
may detect glaucomatous damage earlier than functional tests (such
as standard visual fields) do. In this course, the role of several
such sophisticated imaging devices will be explored in the early
detection of glaucoma.
14.30 - 16.00 Room L
OOG/EOPS/SOE Course
C02 - Management of retinoblastoma
Moderator: Stefan Seregard, Sweden
Moderator: Laurance Desjardins, France
Current management of retinoblastoma at Curie institute; the use and
indications of chemothermotherapy and results of Curie 1998 protocol
Laurance Desjardins, France
Current management of retinoblastoma in Sweden
Stefan Seregard, Sweden
Current management of retinoblastoma in Denmark
Niels Ehlers, Denmark
The outcome of late retinoblastomas and their histopathological
pattern
Doris Hadjistilianou, Italy
Are the visual results of primary chemotherapy for retinoblastoma as
good as those of lens-sparing radiotherapy?
John Hungerford, United Kingdom
Synopsis:
This course will highlight the dramatic changes which have been made
in the management of primary intraocular retinoblastoma during the
previous decade. Systemic chemotherapy combined with focal tumour
consolidation is now the primary management for bilateral disease
and external beam radiotherapy is used as salvage therapy after
failed chemotherapy. Given this change of concept, this course
focuses on the similarities and differences of modern retinoblastoma
management in tertiary referral centres across Europe.
Educational level: Advanced
14.30 - 16.00 Room N
SOE Course
C03 - Management of giant cell arteritis
Moderator: Elizabeth Graham, United Kingdom
The pathogenesis of giant cell arteritis
Cornelia Weyand, United States
Imaging in giant cell arteritis
Wolfgang A. Schmidt, Germany
Arteritic ischaemic optic neuropathy, clinical manifestations and
treatment
Anthony Arnold, United States
Other ophthalmic manifestations of giant cells arteritis
Elizabeth Graham, United Kingdom
Other ophthalmic manifestations of giant cells arteritis
Miles Stanford, United Kingdom
Synopsis:
This course describes new thoughts on the pathogenesis of giant cell
arteritis and methods of imaging to detect both extent and severity
of disease. The ophthalmological complications are described in
detail: although arteritic ischaemic optic neuropathy is featured in
a special talk together with the evidence for the benefit of
treatments, new and old, the rarer retinal and choroidal
manifestations of the disease will be described as well as the
neurophthalmological presentations of the disease.
Objectives
At the conclusion of this course the attendee will be able to
recognise even the atypical case of giant cell arteritis, what
ancillary investigations could be helpful in confirming the
diagnosis, and the rationale, if any, of giving treatment other than
corticosteroids.
Educational level: basic, intermediate & advanced
16.30-18.00 Room I
ESCRS/SOE Course
C04 - Evidence and controversies about IOLs
Moderator: Marie-José Tassignon, Belgium
Moderator: Paul Rosen, United Kingdom
Myth and truth on new IOL optics
Manfred Tetz, Belgium
Current achievements in accommodation after cataract surgery
David Spalton, United Kingdom
Posterior capsule opacification: evidence and new concepts
Oliver Findl, United Kingdom
Is PCCC safe for the eye?
Marie-José Tassignon, Belgium
The retina and the refractive surgeon
Paul Rosen, United Kingdom
Synopsis:
In this course the optical properties of different IOLs available
nowadays will be discussed. The physiological consequences of IOL
implantation resulting in the blood-aqueous barrier breakdown will
be emphasized as well. Quality of vision as a result of IOL
implantation can be evaluated by the induced glare, contrast
sensitivity and aberrations. At the conclusion of this course the
attendee will be taught that his/her choice of the IOL will depend
on his/her knowledge of the IOL will depend on his/her knowledge
about the optical and the physiophatological parameters which both
will define the quality of the image the patient will perceive after
cataract surgery.
SUNDAY, JUNE 10
08.30 - 10.00 Room L
SOE Course
C05 - Surgical management of keratoconus
Moderator: Gabriel van Rij, The Netherlands
Intrastromal corneal implants
Joseph Colin, France
Keratoplasty in keratoconus
Massimo Busin, Italy
Mushroom keratoplasty in keratoconus
Gabriel van Rij, The Netherlands
Synopsis:
Surgical management of keratoconus has undergone a tremendous
transformation during the last years with the implantation of intra
corneal ring segments and mushroom keratoplasties.
The course will present the different techniques and their results.
Mushroom keratoplasty is a modified penetrating keratoplasty
technique for patients with a very steep cornea and/or central
scars.
It combines the refractive advantages of a large anterior lamellar
keratoplasty of 9 mm with a smaller replacement of healthy recipient
endothelium (6-7 mm).
The advantages of the “lap-joint” configuration of the mushroom will
be discussed.
The surgical technique including preparation of the recipient bed
and donor lamellae will be illustrated. This includes the use of an
artificial anterior chamber and a microkeratome.
Special attention will be given to the very important suturing
technique.
At the end of the course the attendees will have acquired new
concepts in the field of implantation of intra corneal ring segments
and keratoplasty surgery with possible application to their surgical
routine.
08.30 - 10.00 Room M
ESA/SOE Course
C06 - Update on botulinum toxin therapy in strabismus
Moderator: John Lee, United Kingdom
Pharmacological properties & mechanisms of action
Constantino Schiavi, Italy
Adulthood strabismus
John Lee, United Kingdom
Childhood strabismus
Rosario Gomez de Liano, Spain
Synopsis:
Botulinum toxin therapy of strabismus was introduced by Dr Alan
Scott of San Francisco in 1979, and has become a popular and
effective alternative to surgical treatment. This course aims to
offer guidelines for effective use of this valuable agent.
Pharmacological properties and mechanisms of action – Prof C.
Schiavi (Bologna)
Botulinum neurotoxin A is one of 7 neurotoxins produced by
Clostridium Botulinum. It acts by inhibiting release of
acetylcholine at the presynaptic membrane of a motor muscle synapse.
Further aspects will be discussed.
Adulthood strabismus –Mr J. Lee (London)
Botulinum toxin is of particular value in the management of adult
strabismus, especially consecutive and secondary (sensory)
strabismus. It also has major applications in management of
paralytic strabismus, especially sixth nerve palsy.
Some types of acquired restrictive strabismus, such as strabismus
following retinal detachment surgery, may also respond well to
treatment.
Childhood strabismus – Prof R. Gomez de Liano (Madrid)
Botulinum toxin may be used in the management of essential infantile
esotropia, with results comparable with or better than surgery.
Other types of childhood strabismus, in particular recently acquired
esotropia and overcorrected exotropia are highly suitable for this
treatment.
10.30 - 12.00 Room I
FAN Club/SOE Course
C07 - Not all retinal Pigmented Epithelium Detachments (PED) are the
same
Moderator: Martine Mauget-Fa˙sse, France
Introduction
Martine Mauget-Fa˙sse, France
Drusenoid, serous PED & vascularized PED in AMD
Maddalena Quaranta-El Maftouhi, France
PED with RAP
Victor Chong, United Kingdom
PED pre-tear & tear characteristics; PED in pattern dystrophies,
Best disease and Best-like changes
Ursula Schmidt-Erfurth, Austria
PED in Polypoidal Choroidal Vasculopathy
Michael Larsen, Denmark
PED in CSC
Yves Salomon Cohen, France
PED in inflammatory diseases, lymphomas and neoplastic and
paraneoplastic ocular syndromes
Bahram Bodaghi, France
PED in multiple myeloma and light chain deposition disease
Anita Leys, Belgium
Synthesis and conclusion
Martine Mauget-Fa˙sse, France
Synopsis:
This course on PEDs will identify and describe all the various
features of this clinical entity through the presentations of:
- Maddalena Quaranta El-Maftouhi: Drusenoid, Serous PED and
vascularized PED in AMD
- Victor Chong: PED with RAP
- Ursula Schmidt-Erfurth: PED pre-tear and tear characteristics; PED
in pattern dystrophies, Best disease, and Best-like changes
- Michael Larsen: PED in Polypoidal Choroidal Vasculopathy
- Yves Salomon Cohen: PED in CSC
- Bahram Bodaghi: PED in inflammatory diseases, lymphomas, and
neoplastic and paraneoplastic ocular syndromes
- Anita Leys: PED in multiple myeloma and light chain deposition
disease.
The course objectives will be to fully describe the anatomical and
clinical features, the evolution, complications and therapeutic
options for each type of PED and to understand their individual
characteristics.
At the conclusion of the course, the attendee will be able to
recognize the various types of PED and decide which therapeutic
options are appropriate.
Educational level: Advanced
10.30 - 12.00 Room L
ROP/EPOS/APOS/SOE Course
C08 - Retinopathy of prematurity
Moderator: John Baker, United States
Moderator: Birgit Lorenz, Germany
Title TBA
Birgit Lorenz, Germany
Title TBA
John Baker, United States
Title TBA
Alistair Fielder, United Kingdom
Title TBA
Gerd Holmström, Sweden
Title TBA
Constanta Nascutzy, Romania
Title TBA
Earl Palmer, United States
Acute ROP: Staging (ICROP classification)
Rasa Sirtautiene, Lithuania
Title TBA
Timothy Stout, United States
Title TBA
Michael Trese, United States
Synopsis:
This workshop on retinopathy of prematurity is designed for
physicians that are in the early stages of a retinopathy of
prematurity screening program or who have been in a screening
program for some time and would like additional information to help
with their screening effectiveness. There will be lecture
presentations on screening criteria, methodology, and schedules,
treatment of retinopathy, when to treat and short and long term
follow-up on these patients with retinopathy of prematurity.
The second part of the workshop will be a panel discussion on
specific cases presented for questions of staging, treatment
threshold and follow-up. In addition, there will be time allotted
for audience questions to be addressed by the panel. The panel will
be made up of an international faculty with extensive retinopathy of
prematurity experience.
10.30 - 12.00 Room M
NEW
SOE Course
C09 - Repair of orbital floor fractures
Moderator: Paul D. Langer, United States
Management of internal orbital floor fractures
Paul D. Langer, United States
Synopsis:
In this course, the orbital anatomy relevant to the patterns of
orbital floor fractures is first reviewed, and the dominant theories
of the pathogenesis of internal orbital floor (i.e., "blow-out")
fractures is then discussed. The indications for surgical repair,
and the timing of such repair, are then described in detail. With
the aid of intraoperative photographs and videos, the inferior
fornix transconjunctival approach to the orbital floor is
demonstrated and techniques for repositing herniated orbital tissue
from the fracture site are described. Specific "pearls" for reducing
these fractures are discussed. The selection and shaping of an
appropriate orbital floor implant, its proper placement, and
techniques of implant fixation are described. Finally, both the
avoidance and management of complications are discussed.
Objective:
At the end of this course, participants should be able to (1)
understand the pertinent orbital anatomy that leads to orbital
blow-out fracture development; (2) know the indications for orbital
floor fracture repair; (3) describe the surgical techniques
necessary for aproaching orbital floor fractures through a
transconjunctival approach and reducing the fracture; and (4)
understand the rationale and the techniques for fixating implants.
14.30 - 16.00 Room M
NEW
AAO/ÖOG/SOE Course
C10 - IOL power calculation
Moderator: Kenneth J. Hoffer, United States
Synopsis:
This course is intended to cover the entire subject of calculating
IOL power for all situations the surgeon would encounter. Emphasis
will be placed on the problems with eyes that have had LASIK surgery
and other perplexing situations. Will cover methods to improve
accuracy of collecting biometric data (axial length, corneal power
and ACD). There will be discussion of ways to handle IOL power
errors when they rarely occur.
Educational level: basic, intermediate & advanced
16.30 - 18.00 Room G
ISCEV/SOE Course
C11 - Clinical electrophysiology in paediatric practice
Moderator: Daphne McCulloch, United Kingdom
Moderator: Jelka Brecelj, Slovenia
Maturation of the ERG and VEP: from preterm infants to preschool
children
Daphne McCulloch, United Kingdom
Why we do visual electrophysiology in infants with congenital
nystagmus?
Jelka Brecelj, Slovenia
Should I do it again? Electrodiagnostic surveillance
Dorothy Thompson, United Kingdom
The paediatric ophthalmologist's view
Tony Moore, United Kingdom
Questions
Synopsis:
Clinical electrophysiologic tests are particularly important for
paediatric patients who may be unable to report symptoms or comply
with subjective tests. Electroretinography (ERG) and visual evoked
potentials (VEP) are specialist tests that can be readily adapted
for infants and young children. This course provides an overview of
normal maturation and clinical applications of these tests,
including case examples, to enhance knowledge and diagnostic
efficiency for both retinal and neuro-ophthamological diseases in
childhood.
This course aims to provide the attendee with an update and thorough
understanding of:
- Normal maturation of the retina and visual pathways measured with
ERGs and VEPs.
- Differential diagnosis of inherited retinal disorders in
paediatric patients.
- Electrophysiology and differential diagnosis in infantile
nystagmus.
- Practical applications of ERGs and VEPs including appropriate
referral, surveillance frequency and interpretation in paediatrics.
16.30 - 18.00 Room I
ESCRS/SOE Course
C12 - Refractive surgery today: an update for the uninitiated
Moderator: Daniel Epstein, Switzerland
Moderator: Ioannis Pallikaris, Greece
Introduction
Daniel Epstein, Switzerland
Modern excimer surface ablation procedures
Ioannis Pallikaris, Greece
State-of-the-art LASIK
Joseph Güell, Spain
LASIK complications
Emrullah Tasindi, Turkey
Intrastromal corneal implants
Joseph Colin, France
Surgical correction of presbyopia
Manfred Tetz, Belgium
Qualtiy of vision after corneal refractive surgery
Marie-José Tassignon, Belgium
Synopsis:
a. The course will provide attendees with a state-of-the-art
overview of modern refractive surgery including excimer corneal
procedures (both advanced surface ablation and LASIK), non-excimer
corneal strategies, and the surgical approach to presbyopia
correction. Because modern refractive surgery is no longer content
with the plain correction of refractive errors, the problems of
quality of vision, which are particularly relevant after corneal
procedures, will also be discussed.
The speakers will aim at presenting the material in such a fashion
as to make it comprehensible to the general ophthalmologist with no
previous expertise in refractive surgery.
b. At the conclusion of the course, the attendees will have become
familiar with some of the most commonly used modern refractive
surgery procedures and the problems associated with them. The
attendees will also be better equipped to discuss refractive surgery
with their patients and to act as their first source of
knowledgeable information.
Educational level: Basic to intermediate
16.30 - 18.00 Room K
SOE Course
C13 - Fluorescein angiographic
diagnosis in macular disease
Moderator: Frank G. Holz, Germany
Moderator: Sebastian Wolf, Switzerland
Instrumentation and basics for fluorescein and ICG angiography
Giovanni Staurenghi, Italy
Infra-red imaging in macular disease
Ulrich Kellner, Germany
Autofluorescence imaging
Frank G. Holz, Germany
The fluorescein angiographic delineation of CNV lesions, treatment
effects
Sebastian Wolf, Switzerland
The fluorescein angiographic detection and classification of
diabetic macular edema
Horst Helbig, Switzerland
Optical coherence tomography for diagnosis and follow-up of macular
edema
Gisele Soubrane, France
Synopsis:
This course will cover the techniques of fluorescein and indocyanine
green angiography as well as infra-red and autofluorescence imaging
in macular diseases. Additionally, the use of optical coherence
tomography for diagnostic and follow-up of macular diseases will be
discussed. The significance of the imaging techniques will be
discussed with special focus on age-related macular degeneration and
diabetic retinopathy.
At the conclusion of this course the attendee will be able to decide
which imaging techniques are most useful for diagnosis and follow-up
of macular diseases.
Educational level: intermediate to advanced
16.30 - 18.00 Room L
SOE Course
C14 - The Boston keratoprosthesis – stepwise introduction
Moderator: Claes H Dohlman, United States
Moderator: John Kanellopoulos,
Greece
Moderator: Leonard Ang, Singapore
Synopsis:
This course will describe the indications, prognostic factors and
outcomes of the Boston Keratoprosthesis. Assembly, surgical
techniques, postoperative regimen and possible complications will
also be stepwise reviewed. Detailed handouts will be available.
Learning Objectives:
Participants with experience in corneal surgery should be able to
successfully perform the keratoprosthesis implantation in
(non-auto-immune) graft failure patients.
Educational Level:
basic, intermediate.
MONDAY, JUNE 11
08.30 - 10.00 Room G
ESOPRS/SOE Course
C15 - Aesthetic aspects of oculoplastic surgery
Moderator: Rudolf F. Guthoff, Germany
Moderator: H.W. Meyer-Rüsenberg, Germany
Moderator: Jean-Paul Adenis, France
Title TBA
Dr Ruban, France
Title TBA
Dr Malet, France
Title TBA
Serge Morax, France
Title TBA
Norbert Pfeiffer, Germany
Title TBA
H.W. Meyer-Rüsenberg, Germany
Synopsis:
The course shows basic and advanced techniques in aesthetic surgery.
It will cover the following topics:
• upper and lower lid blepharoplasty
• combined surgery in complicated blepharoplasty
• midface and malar lifting
• use of different lasers in aesthetic indications
• application of fillers and botulinum toxin
08.30 - 10.00 Room H
EGS/SOE Course
C16 - Devices in glaucoma surgery
Moderator: Tarek Shaarawy, Switzerland
Title TBA
Schlomo Melamed, Israel
Title TBA
Keith Barton, United Kingdom
08.30 - 10.00 Room I
SOIE/SOE Course
C17 - How to reach a diagnosis in uveitis through simple clinical
observation and oriented diagnostic tests
Moderator: Carl P. Herbort, Switzerland
Moderator: Carlos E. Pavésio, United Kingdom
Moderator: Bahram Bodaghi, France
Introduction: the background, epidemiology and classification of
uveitis
Carl P. Herbort, Switzerland
Simple clinical observation and a minimum of tests are sufficient to
diagnose the patient with anterior uveitis
Carl P. Herbort, Switzerland
Uveitis associate with JIA: detecting and managing the severe cases
Bahram Bodaghi, France
Differential diagnosis and investigational tests of intermediate
uveitis
Carlos E. Pavésio, United Kingdom
The differential diagnosis of the most frequent posterior uveitides
Nikos Markomichelakis, Greece
The most common causes of retinal vasculitis and how to detect
emergency situations
Ilknur Tugal-Tutkun, Turkey
Emergencies in posterior uveitis and how to recognize them
Bahram Bodaghi, France
Cases and discussion
Synopsis:
This course is meant for every ophthalmologist interested in dealing
with uveitis patients, especially those that have been discouraged
by uveitis specialists with the argument that the topic is too
difficult for non specialists. Key elements will be given to
consider diagnostic options and orient the investigations into the
proper direction. A rational approach will be favoured instead of
the compilatory and confusing approach put forward in most uveitis
books at the origin of the present mystification. The situations
where specialized help is needed will be exposed, giving more
security to the ophthalmologist seeing uveitis patients who will be
able to decide when referral of patients is indicated.
Educational level: basic, intermediate & advanced
10.30 - 12.00 Room I
ESA/SOE Course
C18 - Case presentations on challenging extraocular muscle problems
Moderator: Emilio Campos, Italy
Title TBA
John Lee, United Kingdom
Title TBA
Constantino Schiavi, Italy
Title TBA
Seyhan Özkan, Turkey
Title TBA
Walter Rüssman, Germany
Title TBA
Rosario Gomez de Liano, Spain
Title TBA
Herman Schworm, Germany
14.30 - 16.00 Room I
ECLSO/SOE
Course
C19 - New concepts in the therapeutic management of dry eye
Moderator: Lorenzo L. Mannucci, Italy
Contact lenses and tears
Juan Murube del Castillo, Spain
Methods and instruments for testing the properties of artificial
tears
Enrico Boldrini, Italy
New concepts in the therapeutic traitment of dry eye: "in vitro" and
clinical experimentations
Lorenzo L. Mannucci, Italy
Synopsis:
The final aim of the course will be to present new therapeutic
treatments in dry eye syndromes, based on different conceptual
approaches to the problem as compared to the past.
First, the role of tears and contact lenses will be focused for
understanding their interactions.
Then instruments and experimental methods for testing the various
properties of artificial tears will be showed in practical way for
explaining the working mechanism of ophthalmic vehicles.
Since none of the marketed viscoelastic compounds is really similar
to the natural mucin, recently a pharmaceutical company demonstrated
that branched-chain polysaccharides only have got a "mucin-like"
chemical structure.
Now another company has just started a new conceptual approach to
dry eye treatment: to use a "mucoadhesive" compound, the
arabinogalactan, instead of "mucomimetic" compounds.
The new two subtances have opposite characteristics and different
indications.
Branched-chain polysaccharides, as mucomimetic, are recommended when
mucous layer is absent; arabinogalactan, as mucoadhesive, is
indicated when mucous layer is altered, but not greatly reduced. For
these reasons, an exact diagnosis of dry eye will be fundamental for
opportune therapy, as the tutors will explain during the course.
14.30 - 16.00 Room K
ÖOG/IOIS/SOE Course
C20 - Uveitis in adults and children: the basics
Moderator: Talin Barisani, Austria
Moderator: Phuc LeHoang, France
Few essential key points in Ocular Immunology
Sofia Androudi, Greece
How to recognize and classify an uveitis: the differentials, the
masquerades
Youssef El-Shabrawi, Austria
How to recognize and classify an uveitis: the differentials, the
masquerades
Phuc LeHoang, France
Evaluation and monitoring of Ocular Inflammation (Laser Photometry,
FA, ICG-A, OCT)
Periklis Brazitikos, Greece
What is specific to childhood uveitis?
Talin Barisani, Austria
How to initiate and monitor treatment: the rheumatologist and
pediatrician’s view
Wolfgang Emminger, Austria
New local and systemic therapies
Marc
D. de Smet, Belgium
Case presentation
Phuc LeHoang, France
Case presentation
Talin Barisani, Austria
Synopsis:
“Uveitis in adults and children: the basics” is a flexible,
case-based short course for both the practicing ophthalmologist and
resident in ophthalmology. The aim is to give an update in
diagnosis, investigation and management, including referral to
secondary care, of common and 'red flag' uveitis conditions. The
course is evidence-based and will include “Clinical Pearls” to
facilitate the diagnosis and the management of uveitis. It will
encourage audit of aspects of the care of patients with Uveitis.
The course will focus on the tailored diagnostic survey,
differential diagnosis and updated therapy options in following
topics:
- Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis
- How to rule out a masquerade syndrome
- Paediatric Uveitis
- New therapeutic modalities
In each topic area scripted cases will be used that allow you to
make a diagnosis and appropriately investigate and manage the
patient. Questions and answers about the case and the topic area
will be promoted, providing a step-by-step approach. The course will
be run by both Uveitis specialists and a Rheumatologist to offer
most appropriate expertise in the subject area.
14.30 - 16.00 Room L
OOG/SOE Course
C21 - Applied statistics for the clinical scientists
Moderator: Bertil Damato, United Kingdom
Moderator: Tero Kivelä, Finland
Applying statistics to the clinical management of uveal melanoma
Bertil Damato, United Kingdom
Is a precise result accurate? – How to write and read statistics
Tero Kivelä, Finland
Synopsis:
An adequate knowledge of statistics is essential for undertaking
research, reviewing manuscripts, and for the routine practice of
evidence-based medicine. However, there are numerous pitfalls that
can seriously mislead the unwary scientist or clinician. This course
will therefore cover the following topics: analysing data from both
eyes; performing statistical comparisons; differentiating clinical
from statistical significance; communicating effect size; and
interpreting survival curves. The course will include examples and
will focus on practical principles, avoiding complicated
mathematics. At the conclusion of this course, the attendee will be
able to avoid a number of important statistical errors when reading
and writing scientific articles.
Educational level: intermediate
16.30 - 18.00 Room I
SOE Course
C22 - Ophthalmoscopic evaluation of the optic disc and retinal nerve
fiber layer
Moderator: Jost B. Jonas, Germany
Synopsis:
Glaucomatous optic neuropathy is characterized by morphologic
changes in the intrapapillary and parapapillary region of the optic
nerve head and in the retinal nerve fiber layer. These changes can
be evaluated using descriptive optic nerve head variables which are
size and shape of the optic disc; size, shape and pallor of the
neuroretinal rim; size of the optic cup in relation to the area of
the disc; configuration and depth of the optic cup; cup-to-disc
diameter ratio and cup-to-disc area ratio; position of the exit of
the central retinal vessel trunk on the lamina cribrosa surface;
presence and location of splinter-shaped haemorrhages; occurrence,
size, configuration and location of parapapillary chorioretinal
atrophy; diffuse and/or focal decrease of the diameter of the
retinal arterioles; and visibility of the retinal nerve fiber layer.
Assessment of these variables is useful for the early detection of
glaucomatous optic nerve damage, to follow-up patients with
glaucoma, to differentiate various types of the chronic open-angle
glaucomas, and to get hints for the pathogenesis of glaucomatous
optic nerve fiber loss.
Educational level: basic, intermediate & advanced
16.30 - 18.00 Room K
SOE Course
C23 -Cataract surgery in uveitis - how to achieve a successful
outcome
Moderator: Carlos E. Pavésio, United Kingdom
Introduction
Carlos E. Pavésio, United Kingdom
Epidemiological aspects and pre-operative care
Miles Stanford, United Kingdom
Intraoperative aspects
Marko Hawlina, Slovenia
Which IOL?
Claudette Abela-Formanek, Austria
Is there a role for combined phaco and vitrectomy?
Sofia Androudi, Greece
Post-operative care and complications
Carlos E. Pavésio, United Kingdom
Paediatric uveitic cataract surgery
Clive Edelsten, United Kingdom
TUESDAY, JUNE 12
08.30 - 10.00 Room K
SOE Course
C24 AMD – New perspectives in pathogenesis and
treatment
Moderator: Frank G. Holz, Germany
Moderator: Daniel Pauleikhoff, Germany
Moderator:
Adnan Tufail, United Kingdom
Moderator: Sebastian Wolf, Switzerland
Epidemiology and pathogenesis of AMD
Daniel Pauleikhoff, Germany
Geographic atrophy
Frank G. Holz, Germany
Genetic factors in AMD
Hendrik Scholl, Germany
Imaging strategies in AMD
Giovanni Staurenghi, Italy
Prophylaxis
Adnan Tufail, United Kingdom
Anti-VEGF therapy
Sebastian Wolf, Switzerland
Case presentations with panel
discussion on AMD therapy including retreatment criteria for
anti-VEGF therapy
Daniel Pauleikhoff, Germany; Adnan Tufail, United Kingdom; Frank G.
Holz, Germany
Synopsis:
This course will give an update on key pathogenetic pathways in AMD
as well as in current and emerging treatment modalities.
Determinants for RPE cell dysfunction, oxidative damage, drusen
biogenesis, secondary inflammatory responses as well as angiogeneic
cascades will be addressed. Pros and cons of treatment modalities
including anti-VEGF-agents (Bevacizumab, Pegabtanib and Ranibizumab),
reinjection criteria and monitoring issues are discussed and latest
results of treatment trials summarized. Along with emerging
prophylactic approaches current clinical management strategies of
patients with various manifestations of AMD including geographic
atrophy is presented.
Educational level:
basic, intermediate & advanced
10.30 - 12.00 Room K
NEW
SOE Course
C25 - Virtual reality ocular surgery
Moderator: Per G. Söderberg, Sweden
Moderator: Carl-Gustav Laurell, Sweden
Virtual reality learning of ocular surgery and its evaluation
Per G. Söderberg, Sweden
The technology behind simulated phacoemulsification surgery
Eva Skarman, Sweden
Very experienced cataract surgeons versus medical/optometry students
measured from virtual reality phacoemulsification surgery
Carl-Gustav Laurell, Sweden
Virtual reality cataract surgery, a tool for teaching cataract
surgery
Wamidh Simawi, Sweden
Virtual reality vitreoretinal surgery
Kaan Saracoglu, Germany
Virtual reality photocoagulation of the retina
Dominique Lamy, France
Synopsis:
This course aims to provide a state of the art summary of virtual
reality (VR) simulation in ophthalmology. The principles of motor
skill learning will be reviewed and related to VR simulators.
Concepts for evaluation of VR motor skill learning will be presented
with an example of a VR phacoemulsification simulator. The
technology behind a commercially available VR phacoemulsification
simulator will be presented. The results of a comparative study
between very experienced cataract surgeons and medical/optometry
students, using a commercially available phacoemulsifiation VR
simulator, will be reviewed. VR unique options for teaching cataract
surgery will be presented. Experience of the first commercially
available vitreoretinal surgery simulator will be presented.
Finally, an evaluation of the first commercially available simulator
for photocoagulation will be given.
Educational level: Basic
10.30 - 12.00 Room N
NEW
ESOPRS/SOE Course
C26 - Immunosuppressive therapy in adnexal and ocular surface
disorders
Moderator: Ulrich Schaudig, Germany
Moderator: Gerd Geerling, Germany
Introduction
Ulrich Schaudig, Germany; Gerd Geerling, Germany
The hot orbit
Lelio Baldeschi, The Netherlands
The swollen lacrimal gland
Geoffrey Rose, United Kingdom
The scarring fornix
Gerd Geerling, Germany
The blocked nasolacrimal ducts
David Verity, United Kingdom
The inflamed lid
Ulrich Schaudig, Germany
The complications
Gerd Geerling, Germany
Synopsis:
Although rare, chronic inflammatory disorders of the ocular surface
and adnexa are more common than generally thought. In severe
disease, topical medications alone will be insufficient to control
the situation. Ophthalmologists often hesitate to or rely upon
rheumatologists to initiate and control systemic immunosuppressive
therapy. This course – entirely run by ophthalmologists – will
describe the spectrum of indications requiring such treatment as
well as common treatment protocols, and guidelines how to avoid,
recognise and treat unwanted side effects.
This course aims to enable the attendee to identify patient’s who
require systemic immunosuppression, decide when and how to initiate
appropriate therapeutic steps and how to manage complications.
14.30 - 16.30 Room H
ECLSO/SOE Course
C27 - Basics in contact lenses: news and views in contactology
Moderator: Albert Franceschetti, Switzerland
Types and materials
Albert Franceschetti, Switzerland
Rigid contact lens: how to begin?
Ursula Vogt, United Kingdom
Soft contact lenses
Ayfer Kanpolat, Turkey
Contact lens care
Xavier Subirana, France
Synopsis:
Recent years have seen dramatic changes in the technology of contact
lenses. New materials, new designs and new products features enable
the
specialist to easily find the best possible lens for each patient,
in
particular one adpated to the patient's personal lifestyle. Yet,
this
field keeps innovating so fast that frequent updates are an absolute
necessity.
The course will start with the review of types and materials,
including
the new silicone-hydrogel versions. This will be followed by the
review
of rigid and soft contact lenses. Finally, the often forgotten
importance of contact lens products will be discussed.
The course will bring you a wealth of up-to-date information and
advice
that cannot be found anywhere else and will greatly improve your
technique of handling contact lenses as well as complications.
14.30 - 16.00 Room N
SOE Course
C28 - The value and perspectives of OCT
Moderator: Ursula Schmidt-Erfurth, Austria
Concept and principles of OCT imaging
John Marshall, United Kingdom
The role of OCT in age-related macular degeneration
Anita Leys, Belgium
The role of OCT in diabetic macular disease
Frank Verbraak, The Netherlands
OCT imaging in surgical disease of the macula
Christian Prünte, Switzerland
The value of the OCT in anti-angiogenic therapy
Kaija Polak, Austria
New perspectives in OCT imaging
Ursula Schmidt-Erfurth, Austria
Synopsis:
This course is composed as a broad base of information on optical
coherence tomography (OCT) for an audience with basic to advanced
knowledge.
The authors will describe the principles of OCT imaging of the
course based on the physical imaging properties and current
technology. The major focus is to provide insight into the clinical
application and value of OCT. The predominant pathologies such as
age-related macular degeneration (AMD) and diabetic maculopathy
(DMP) will we highlighted with demonstration of clinically relevant,
classic and unusual OCT features. The role of OCT in macular surgery
is illustrated with OCT images demonstrating the change in the
retinal architecture. The benefit of OCT as a diagnostic tool for
treatment indication or retreatment during follow-up is presented
and discussed with particular emphasis on antiangiogenic therapy.
The novel technology including high-resolution, threedimensional OCT
imaging with the possibility to quantify retinal edema and
pathologic volumes is introduced for the expert.
At the conclusion of this course the participant will be fully
equipped to perform OCT readings of common clinical disease and have
a precise vision of the upcoming perspectives of this important
modality.
16.30 - 18.00 Room D
SOE Course
C29 - Intraocular therapy for retinal disease
Moderator: Sue Lightman, United Kingdom
Moderator: Peter McCluskey, Australia
Intraocular steroids which are injectable
Peter McCluskey, Australia
Steroid implants
Sue Lightman, United Kingdom
Anti-VEGF compounds
Richard Andrews, United Kingdom
How to give intravitreal injections safely
Simon Tatlor, United Kingdom
Synopsis:
The aim of this course is to update the participant on intravitreal
therapy for diabetic retinopathy, retinal vascular occlusions, age
related macular disease and uveitis. The latest information on all
types of intravitreal steroids and anti-VEGF compounds will be
presented by experts in the field. In addition we will show you how
to do an intravitreal injection safely, taking you through it step
by step and illustrating the steps with a video and provide you with
a detailed instruction sheet to take home.
1. Intraocular steroids which are injectable: Prof Peter McCluskey
2. Steroid implants: Prof Sue Lightman
3. Anti-VEGF compounds: Mr Richard Andrews
4. How to give intravitreal injections safely: Mr Simon Taylor
16.30 - 18.00 Room I
Austrian Glaucoma Society/SOE Course
C30 - Glaucoma treatment - one drug or two?
Moderator: Anton Hommer, Austria
Moderator: Andrea Mistlberger, Austria
Fixed combinations - an overview
Anton Hommer, Austria
How and what to combine?
Christoph Faschinger, Austria
How to improve compliance?
Karl Rigal, Austria
Everyday life - case presentations
Andrea Mistlberger, Austria
Synopsis:
For most of our glaucoma patients and ocular hypertensives medical
therapy still is the first step of treatment.
Treatment should be as simple, effective, tolerable and affordable
as possible. Although medications improved with their IOP-lowering
effect and persistency, many patients do need combination therapy.
When should we start to combine? Which drugs should be used ?
Besides fixed combinations there exist many more modalities to
combine antiglaucomatous drugs. Most of these drugs work together
quite well, some don’t. A brief overview shows the mechanisms of
actions and efficacy.
As in all chronic diseases patients´ non compliance is also one of
the challenges in the management of glaucoma.
Different types of non-compliance require different types of
counteracting measures. Examples will be discussed.
Educational level: basic, intermediate & advanced
|
|
